LncRNA IL21-AS1 facilitates tumour progression by enhancing CD24-induced phagocytosis inhibition and tumorigenesis in ovarian cancer
Open Access
- 3 May 2024
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (5) , 1-14
Abstract
CD24 is overexpressed in various tumours and considered a regulator of cell migration, invasion, and proliferation. Recent studies have found that CD24 on ovarian cancer (OC) and triple-negative breast cancer cells interacts with the inhibitory receptor sialic-acid-binding Ig-like lectin 10 (Siglec-10) on tumour-associated macrophages (TAMs) to inhibit phagocytosis by macrophages. Because of its multiple roles in regulating the immune response and tumorigenesis, CD24 is a very promising therapeutic target. However, the regulatory mechanism of CD24 in OC remains unclear. Here, we found that the long noncoding RNA (lncRNA) IL21-AS1, which was upregulated in OC, inhibited macrophage-mediated phagocytosis and promoted OC cell proliferation and apoptosis inhibition. More importantly, after IL21-AS1 knockdown, a significant survival advantage was observed in mice engrafted with tumours. Mechanistically, we identified IL21-AS1 as a hypoxia-induced lncRNA. Moreover, IL21-AS1 increased HIF1α-induced CD24 expression under hypoxic conditions. In parallel, we found that IL21-AS1 acted as a competing endogenous RNA (ceRNA) for miR-561-5p to regulate CD24 expression. Finally, IL21-AS1 increased CD24 expression in OC and facilitated OC progression. Our findings provide a molecular basis for the regulation of CD24, thus highlighting a potential strategy for targeted treatment of OC.Keywords
Funding Information
- National Natural Science Foundation of China (81772762, 81802376)
- Natural Science Foundation of Shanghai Municipality (21ZR1450900)
This publication has 62 references indexed in Scilit:
- Non-coding RNAs and potential therapeutic targeting in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- Novel insights into the function of CD24: A driving force in cancerInternational Journal of Cancer, 2020
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic TargetsCancer Cell, 2019
- Overview of CD24 as a new molecular marker in ovarian cancerJournal of Cellular Physiology, 2018
- Long Noncoding RNAs in Cancer PathwaysCancer Cell, 2016
- Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolismCancer Letters, 2016
- Lentivirus Production and Purification2016
- CD24 controls Src/STAT3 activity in human tumorsCellular and Molecular Life Sciences, 2012
- Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis RevisitedCancer Cell, 2009
- Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and MetastasisCell, 2006